Gilead Sciences Inc
GILD XNAS
$131.33
-2.73 (-2.04%)
▼
15-min delayed
Open
$130.00
High
$133.34
Low
$129.00
Volume
10.25M
Market Cap
$163.06B
About Gilead Sciences Inc
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
Key Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $6.96B | $2.02B | $1.63 |
| FY 2025 | $29.44B | $8.51B | $6.84 |
| Q3 2025 | $7.77B | $3.05B | $2.46 |
| Q2 2025 | $7.08B | $1.96B | $1.57 |
Earnings & Analyst Ratings
Next Earnings:
Wed, Aug 5, 2026
Calendar →
TickerDaily Coverage
Stock Market Today, April 26, 2026: Stocks to Watch This Week — Earnings, Catalysts, and Setups
Market News
David Brooks · Apr 27, 2026
As of Sunday, April 26, 2026, the market is positioning for a heavy earnings week ahead. Twelve...
Stock Market Today, April 12, 2026: Big Week Ahead — 15 Earnings, Rate Signals, and Key Setups
Market News
David Brooks · Apr 13, 2026
Sunday evening market prep: 15 major earnings reports land next week (April 20-24), with Amazon,...
Healthcare Stocks This Week: XLV Ends Mixed as Pharma Giants Face Margin Pressures (Mar 23–27, 2026)
Market News
David Brooks · Mar 27, 2026
The healthcare sector finished Friday, March 27, 2026 in neutral territory as investor focus...
Why Is Arcellx, Inc. Common Stock (ACLX) Stock Up 77.4% Today?
Market News
Alex Chen · Feb 24, 2026
Arcellx stock exploded 77.4% to $113.75 on a massive 32.9M-share volume surge after Gilead Sciences...
Why Is Arcellx, Inc. Common Stock (ACLX) Stock Up 77.7% Today?
Market News
Alex Chen · Feb 23, 2026
Arcellx stock exploded 77.7% today after Gilead Sciences announced it would acquire the...
View All Coverage →
Get GILD Alerts
Stay ahead with breaking news, price alerts, and expert analysis on Gilead Sciences Inc.
Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.